MRNADVANCE

Serial Number 98211073
Registration 7630312
700

Registration Progress

Application Filed
Oct 5, 2023
Under Examination
Approved for Publication
Nov 12, 2024
Published for Opposition
Nov 12, 2024
Registered
Dec 31, 2024

Trademark Image

MRNADVANCE

Basic Information

Serial Number
98211073
Registration Number
7630312
Filing Date
October 5, 2023
Registration Date
December 31, 2024
Published for Opposition
November 12, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 31, 2024
Registration
Registered
Classes
005 009 042

Rights Holder

Samsung Biologics Co., Ltd.

99
Address
300, Songdo bio-daero
Yeonsu-gu, Incheon 21987
KR

Ownership History

Samsung Biologics Co., Ltd.

Original Applicant
99
Yeonsu-gu, Incheon KR

Samsung Biologics Co., Ltd.

Owner at Publication
99
Yeonsu-gu, Incheon KR

Samsung Biologics Co., Ltd.

Original Registrant
99
Yeonsu-gu, Incheon KR

Legal Representation

Attorney
Lisa C. Pavento

USPTO Deadlines

Next Deadline
1986 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-12-31)
Due Date
December 31, 2030
Grace Period Ends
June 30, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description Documents
Dec 31, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 31, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 12, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 12, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 23, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 1, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 24, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Sep 24, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Sep 24, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Sep 24, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Sep 13, 2024 ALIE A ASSIGNED TO LIE Loading...
Sep 13, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 13, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 26, 2024 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Feb 8, 2024 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Feb 8, 2024 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Feb 8, 2024 CNSL R SUSPENSION LETTER WRITTEN Loading...
Feb 1, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 31, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 31, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 7, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 7, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 7, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 30, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 14, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 9, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Reagents for medical use for measurement of HBs antibody; medicines consisting of RNA for treating cancer; crude medicines for treating ocular diseases; cellular function activating agents for medical purposes; colostral antibodies for veterinary purposes; chemico-pharmaceutical preparations for treating cancer; chemical preparations for use in DNA analysis for medical purposes; chemical preparations for use in RNA analysis for medical purposes; bacterial preparations for medical and veterinary use; chemical preparations for treating cancer for medical or veterinary purposes; biotechnological preparations for medical purposes, namely, reagents for medical purposes; biological reagents for medical purposes; biochemical preparations for medical purposes; reagents for medical use; bispecific colostral antibody for medical use; trace element preparations being dietary supplements for human use; clinical medical reagents; pharmaceutical preparations for the treatment of cancer; medical diagnostic reagents for the detection of mRNA antigens; colostral antibodies for medical purposes
Class 009
DNA analysis apparatus, namely, medical laboratory research instruments for DNA analysis; DNA chips; RNA microarrays; cartridges for storing specimen used for RNA analysis apparatus, namely, solid phase extraction cartridges for laboratory use; reagent cartridges used for RNA analysis apparatus, namely, solid phase extraction cartridges for laboratory use; reagent containers used for RNA analysis apparatus, namely, solid phase extraction cartridges for laboratory use; RNA analysis apparatus, namely, medical laboratory research instruments for RNA analysis; RNA sequencing devices, namely, laboratory devices for detecting genetic sequences; RNA chips; genome analyzer machines, namely, laboratory devices for detecting genetic sequences and related downloadable computer operating software; devices for analyzing genome information, namely, laboratory devices for detecting genetic sequences; bioreactors for cell culturing for scientific research; biochip analyzing apparatus for research or scientific purposes; biochip sensors for sensing antigens; biochips for research or scientific purposes; liquid dosage devices that measure the amounts to be dispensed, namely, dispensers for measuring and dispensing of distilled water, not for medical use; incubators for cell culture, not for medical purposes; cellchip inspectors being optical inspection apparatus; devices for analyzing protein sequence used as laboratory apparatus, namely, laboratory devices for detecting genetic sequences; physical and chemical machines for laboratory use; physical and chemical apparatus for analyzing genes, namely, laboratory devices for detecting genetic sequences; gene amplifiers being DNA microarrays; mRNA microarrays; RNA, MRNA, and DNA microarrays; nucleic acid sequencing devices and nucleic acid synthetic apparatus, namely, laboratory devices for detecting genetic sequences; diagnostic chips for inspecting blood plasma laboratory apparatus, namely, DNA chips; diagnostic chips for analyzing blood plasma laboratory apparatus, namely, DNA chips
Class 042
RNA technology research and development; providing temporary use of non-downloadable web application for sharing information in the RNA technology field; research in the field of RNA repair technology; research and development of RNA chips; research relating to science, namely, scientific research in the field of RNA; RNA screening for scientific research purposes; RNA sequence analysis for scientific research purposes; multiple nucleic acid analysis for scientific research purposes; molecular analysis for scientific research purposes; development of new technology for others in the field of biotechnology; biochemical analysis; drug discovery services; design of new products for others; pharmaceutical research and development; clinical studies of medicines, namely, conducting clinical trials for others; services for assessing the efficiency of pharmaceuticals, namely, product quality testing services; fusion protein analysis for scientific research purposes; computer programming services in the medical field; medical laboratories; management assistance services for medical image data, namely, engineering services; medicine research being medical research; analysis and evaluation of medical product development, namely, product quality testing services; providing scientific information on the testing, inspection and research of medical products; scientific and medical laboratory services relating to the production of bispecific antibody antibodies; pharmaceutical drug development for bispecific antibody; bispecific antibody research and development; evaluating of clinical trial progress, namely, conducting clinical trials for others; clinical trials, namely, conducting clinical trials for others; providing temporary use of online, non-downloadable computer operating software for genome analyzer machines

Additional Information

Pseudo Mark
MRN ADVANCE

Classification

International Classes
005 009 042